Wang JY, Liu Y, Wang L, Sun
iu ny c khng nh trong sch gio khoa ayurveda m cn trong cc ti liu tham kho tiu chun nh Dc in n , Anh v Hoa K (cc thng s k thut ca h hon ton da trn r ca cy Ashwagandha ) TI SAO BN NN LA CHN KSM-66 ASHWAGANDHA KSM-66 Ashwagandha l chit xut c nng cao nht trong tt c cc loi chit xut r cy Ashwagandha, ng thi c rt nhiu l do m bn nn chn s dng sn phm c ngun gc Ashwagandha t KSM-66: (1) KSM-66 l chit xut r cy ph rng c nng cao nht v c kh dng sinh hc cao nht trn th trng hin nay, gi nguyn tt c cc thnh phn t nhin ca tho mc theo trng thi cn bng ban u
Immunoblotting Cell pellets were washed twice with ice-cold PBS prior to lysis in RIPA buffer (10 mM Tris-Cl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS) supplemented with protease inhibitors Sigma-Aldrich, 11836170001) and phosphatase inhibitors (Roche, 04906837001)
The combined model first provided visualisation of quinone redox-metabolism by capturing the transitions between Q, SQ . and H 2 Q, as well as the subsequent production of O 2 . over a 30-minute time-span